X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs STERLING BIOTECH - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD STERLING BIOTECH ALEMBIC LTD/
STERLING BIOTECH
 
P/E (TTM) x 119.7 -2.0 - View Chart
P/BV x 4.4 0.1 5,680.8% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 ALEMBIC LTD   STERLING BIOTECH
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
STERLING BIOTECH
Dec-13
ALEMBIC LTD/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs5311 502.9%   
Low Rs293 861.8%   
Sales per share (Unadj.) Rs4.726.8 17.6%  
Earnings per share (Unadj.) Rs8.8-15.0 -58.7%  
Cash flow per share (Unadj.) Rs9.0-5.5 -164.8%  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.754.9 50.5%  
Shares outstanding (eoy) m267.03267.87 99.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.70.3 3,354.7%   
Avg P/E ratio x4.7-0.5 -1,006.9%  
P/CF ratio (eoy) x4.6-1.3 -358.4%  
Price / Book Value ratio x1.50.1 1,169.1%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,9621,862 588.8%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m238547 43.5%   
Avg. sales/employee Rs ThNM5,303.3-  
Avg. wages/employee Rs ThNM403.8-  
Avg. net profit/employee Rs ThNM-2,959.0-  
INCOME DATA
Net Sales Rs m1,2607,181 17.6%  
Other income Rs m26443 619.2%   
Total revenues Rs m1,5247,223 21.1%   
Gross profit Rs m83947 8.7%  
Depreciation Rs m612,543 2.4%   
Interest Rs m04,377 0.0%   
Profit before tax Rs m285-5,931 -4.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m6-1,924 -0.3%   
Profit after tax Rs m2,343-4,007 -58.5%  
Gross profit margin %6.613.2 49.8%  
Effective tax rate %2.132.4 6.6%   
Net profit margin %185.9-55.8 -333.2%  
BALANCE SHEET DATA
Current assets Rs m1,68914,335 11.8%   
Current liabilities Rs m48649,809 1.0%   
Net working cap to sales %95.4-494.0 -19.3%  
Current ratio x3.50.3 1,206.9%  
Inventory Days Days217403 53.8%  
Debtors Days Days81171 47.5%  
Net fixed assets Rs m1,62455,432 2.9%   
Share capital Rs m534268 199.4%   
"Free" reserves Rs m5,96013,935 42.8%   
Net worth Rs m7,40414,701 50.4%   
Long term debt Rs m1049,478 1.1%   
Total assets Rs m8,01073,988 10.8%  
Interest coverage x950.7-0.4 -267,822.8%   
Debt to equity ratio x00.6 2.2%  
Sales to assets ratio x0.20.1 162.1%   
Return on assets %29.30.5 5,839.8%  
Return on equity %31.6-27.3 -116.1%  
Return on capital %31.3-6.4 -486.9%  
Exports to sales %2.925.9 11.4%   
Imports to sales %28.90.2 16,985.0%   
Exports (fob) Rs m371,860 2.0%   
Imports (cif) Rs m36412 2,981.1%   
Fx inflow Rs m371,860 2.0%   
Fx outflow Rs m36525 1,466.2%   
Net fx Rs m-3281,835 -17.9%   
CASH FLOW
From Operations Rs m3461,719 20.1%  
From Investments Rs m-48-3,148 1.5%  
From Financial Activity Rs m-3011,426 -21.1%  
Net Cashflow Rs m-3-3 88.2%  

Share Holding

Indian Promoters % 64.0 33.9 188.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.0 -  
FIIs % 9.7 9.9 98.0%  
ADR/GDR % 0.0 16.9 -  
Free float % 26.1 39.3 66.4%  
Shareholders   54,701 21,482 254.6%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   ALKEM LABORATORIES  PLETHICO PHARMA  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Crash in Bitcoin, Correction in MidCap and SmallCap Indices and Top Stocks in Action Today(Pre-Open)

The past year has seen the BSE MidCap and BSE SmallCap indices surging by 43.1% and 57.1% respectively. Taking a two year view these indices have produced mind-boggling return of 75.3% .

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jan 17, 2018 09:17 AM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS